Looking for an alarm system to make you feel more secure? We've tested all the best professional and DIY home security systems to help you decide which is right to protect your family and property.

Thanks to smart home security systems, it's easier and more affordable than ever to monitor your home from pretty much anywhere. At PCMag, we have been reviewing smart home security solutions for ...

In addition to the CMV assay, Roche has CE-IVD viral load tests for HIV-1, HCV, HCV genotyping (GT), and HBV for the cobas 4800 System, representing a complete portfolio of viral load monitoring ...

Lilienfeld said that while the instrument's integration with the larger Cobas Pro system makes it a straightforward fit for existing Roche customers, the company also sees it as a potential "door ...

If anything, the gap understates the gulf between the soft-spoken, beetle-browed Hoffmann, who is the great-grandson of Fritz Hoffmann-La Roche, founder of pharmaceuticals group Roche, and the ...

Roche has a big problem. With competition threatening some of its older and most lucrative biologic drugs, the Swiss pharmaceutical giant expects that, between 2023 and 2028, sales from these assets ...

Sir Brian Roche says there is a concern about the level of analysis given to Treaty "breaches". Photo / Marty Melville There are too many meetings in the public service, too many layers of ...

Wing Commander Clive Beadon’s collection of medals was sold on Wednesday morning by Noonans Mayfair for £4,800. His son, John Beadon, put in a bid of £2,400 for the collection, which included ...

Roche Eyes Judicious Use of $10B M&A Budget Every year, Roche sets aside around $10 billion for potential M&A deals, but CEO Teresa Graham revealed at JPM25 that the pharma is selective in how and ...

Meme coins aren’t just about financial gains; they reflect the growing influence of cryptocurrency and internet culture. For younger investors, the fast-paced and unpredictable nature of meme ...

Roche's Tecentriq could become the first drug in the PD-1/PD-L1 inhibitor class to be approved in a subcutaneous formulation, after the new version matched the original intravenous formulation in ...